Bladder cancer therapy trang 1 tải miễn phí từ TAILIEUCHUNG

"Bladder cancer therapy" trang 1 - tải miễn phí từ Tailieuchung

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

9 64 1

Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: A retrospective non-randomized comparative study

Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: A retrospective non-randomized comparative study

11 40 1

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review

15 45 1

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

10 59 0

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model

8 31 1

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies

15 28 1

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)

9 71 0

Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p

Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p

12 15 1

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

11 8 1

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response

4 63 1

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscleinvasive bladder cancer (EFFORT-MIBC): A phase II prospective trial

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscleinvasive bladder cancer (EFFORT-MIBC): A phase II prospective trial

7 46 1

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

14 11 1

Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

Epicure: A European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy

9 32 1

Guidelines on Bladder Cancer Muscle-invasive and Metastatic

Guidelines on Bladder Cancer Muscle-invasive and Metastatic

1 70 0

Báo cáo hóa học:

Báo cáo hóa học: " The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial"

6 44 0

Báo cáo hóa học:

Báo cáo hóa học: " Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences"

18 41 0

Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran - a randomized controlled trial

Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran - a randomized controlled trial

8 12 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.